Brickell Biotech is a clinical-stage pharmaceutical company that is working to develop innovative prescription therapeutics that can treat skin diseases. The company's focus is on debilitating skin conditions such as hyperhidrosis and other prevalent dermatological conditions. With its executive management team and board of directors bringing extensive experience in product development and global commercialization, Brickell aims to develop and commercialize innovative products that can be successful in the currently underserved dermatology global marketplace. The company's pipeline consists of potential novel therapeutics, and its strategy is to leverage its experience to in-license, acquire, develop, and commercialize innovative products.
Brickell Biotech, Inc.'s ticker is BBI
The company's shares trade on the NASDAQ stock exchange
They are based in Boulder, Colorado
There are 11-50 employees working at Brickell Biotech, Inc.
It is https://brickellbio.com/
Brickell Biotech, Inc. is in the Healthcare sector
Brickell Biotech, Inc. is in the Biotechnology industry
The following five companies are Brickell Biotech, Inc.'s industry peers: